LiverPRO Reduces False Positives and Screening Costs Compared With Fibrosis-4 Index in Steatotic Liver Disease. // Clinical Gastroenterology and Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S1542356526000522?dgcid=rss_sd_all
LiverPRO Reduces False Positives and Screening Costs Compared With Fibrosis-4 Index in Steatotic Liver Disease. Clinical Gastroenterology and Hepatology. https://www.sciencedirect.com/science/article/pii/S1542356526000522?dgcid=rss_sd_all
“LiverPRO Reduces False Positives and Screening Costs Compared With Fibrosis-4 Index in Steatotic Liver Disease.” Clinical Gastroenterology and Hepatology.
@article{article41094,
title = {LiverPRO Reduces False Positives and Screening Costs Compared With Fibrosis-4 Index in Steatotic Liver Disease},
journal = {Clinical Gastroenterology and Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S1542356526000522?dgcid=rss_sd_all}
}